OSS, Netherlands, Nov. 29, 2021 /PRNewswire/ — BioConnection, an impartial CDMO (Contract Development Manufacturing Organization) primarily based in Oss, The Netherlands, specialised in GMP-certified manufacturing of sterile drug merchandise in vials and syringes, right now introduced that Nykode Therapeutics AS, (previously Vaccibody) (Euronext Growth Oslo: VACC), chosen BioConnection for the aseptic drug product manufacturing of its lead vaccine candidate.  Nykode Therapeutics is a scientific stage biotechnology firm, growing vaccines and novel immunotherapies for the therapy of most cancers and infectious illnesses with a excessive unmet medical want.

Mette Husbyn, CTO of Nykode, mentioned: 

“We selected to companion with BioConnection for the manufacturing of Nykode’s valuable scientific trial materials due to their tailor-made options for manufacturing, matching the necessities for small scale batches. Moreover, BioConnection has a wonderful broad manufacturing and regulatory monitor report, together with EMA and FDA certification.”

BioConnection’s CEO Alexander Willemse provides:

“Phase I trials normally require small batches of drug merchandise that need to be delivered in a exact method. Capitalizing on our years of expertise, we provide automated filling in giant volumes as much as 40 million vials per yr, and importantly additionally handbook fill and end. I’m very completely happy that our manufacturing capabilities, completely match Nykode’s actual early section scientific trial wants.”

About BioConnection

BioConnection, primarily based in Oss, The Netherlands, is a contract producer for the GMP manufacturing of sterile drug merchandise (in vials or syringes) for scientific trial packages and industrial functions. Its state-of-the-art GMP manufacturing facility is EMA and US-FDA licensed, the corporate has greater than fifteen years of expertise and serves a worldwide buyer base. BioConnection provides full drug product service packages, together with filling and freeze drying, technical switch, scale-up, course of validation, analytical assist, stability research, label & pack (incl. serialization) and ultimate batch certification to clinic or market. Delivering from 4 aseptic filling strains (class A), BioConnection can match portions which are required for personalised drugs, scientific trial packages and industrial functions.

Recently, BioConnection has been granted GMP Certification for manufacturing of sterile drug merchandise on their model new giant scale filling line, considerably growing its manufacturing capability and thus guaranteeing future firm development. The new manufacturing line, which has been validated as per the EMA and US-FDA high quality pointers, has an annual manufacturing capability of as much as 40 million vials for liquid merchandise and as much as 4 million vials for freeze-dried merchandise.

Learn extra at www.bioconnection.eu

Oss, The Netherlands
Alexander Willemse, CEO
T: +31 (0) 412 637 937
E: alexander.willemse@bioconnection.eu

For Media:

LifeSpring LifeSciences Communication, Amsterdam
Leon Melens
T: +31 6 538 16 427
E: lmelens@lifespring.nl

Logo – https://mma.prnewswire.com/media/1697425/BioConnection_Logo.jpg

SOURCE BioConnection


Source link

#BioConnection #manufacture #scientific #trial #materials #Nykode #Therapeutics #vaccine

By Seth A. Dunbar

Seth Dunbar leads clinical research study operations and quality & compliance. He is experienced working with teams to help drug sponsors better leverage eSource data. With 10+ years of experience Seth brings expertise developing eClinical services that integrate data and technology to help companies optimise study execution.

Leave a Reply

Your email address will not be published. Required fields are marked *